Skip to main content
Skip to main content
ICCO logo

InterCare DX, Inc. (ICCO)

$0.00 +$0.00 (+0.00%) |CouncilHOLD · 47 · C
Bottom line: HOLD — our Council read (47/100) and AI Score (47/100) broadly agree.
MCap: 2K| Vol: 3.2K| 52-wk range: $0.00 – $0.09
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

InterCare DX, Inc. (ICCO) trades at $0.00 with AI Score 47/100 (Grade C). InterCare DX, Inc. Market cap: $1,990, Sector: Healthcare.

Price live · AI analysis from Jun 15, 2026
InterCare DX, Inc. develops and delivers specialized software solutions with a focus on the biomedical sector, offering applications for relaxation, stress management, and integrated enterprise systems. The company's product suite spans healthcare, education, hospitality, and human capital management, leveraging internet-ready and RFID technologies.

Analyst Coverage for ICCO: ICCO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ICCO against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 47/100 · C

ICCO: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

InterCare DX, Inc. (ICCO) Healthcare & Pipeline Overview

CEOAnthony C. Dike
HeadquartersHawthorne, United States
IPO Year2009

InterCare DX, Inc. provides diverse software solutions across healthcare, education, and enterprise sectors, including clinical management, vascular diagnostics, and e-learning platforms. Operating as a subsidiary of Meridian Holdings, Inc., the company leverages multimedia and RFID technologies to deliver specialized applications for various administrative and wellness needs.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 15, 2026

What Is the Investment Thesis for ICCO?

InterCare DX, Inc. presents an investment thesis centered on its diverse software solutions catering to growing sectors like healthcare information services, education technology, and corporate wellness. The company's offerings, such as the "InterCare Clinical Explorer" and "e-Learning Integrated Technology Enterprise Systems," address critical needs for operational efficiency and data management in large, complex organizations. The "InterCare Vascular Diagnostic Center" taps into the increasing demand for preventive healthcare technologies. However, the company's extremely low market capitalization of 2K and its listing on the 'OTC Other' tier signify substantial financial and regulatory risks, including potential liquidity challenges and limited public disclosure. The negative Beta of -2.49 suggests an inverse relationship with market movements, which can be indicative of unique, company-specific factors or low trading volume. Investors should meticulously evaluate the company's business strategy, compliance efforts, and potential for market penetration for its specialized software solutions against the backdrop of its current financial standing and OTC market limitations.

Based on FMP financials and quantitative analysis

ICCO Key Highlights

  • InterCare DX, Inc. maintains an extremely low market capitalization of 2K, reflecting its early stage or limited public market presence.
  • The company exhibits a Beta of -2.49, indicating a significant inverse correlation to broader market movements, which may suggest unique operational dynamics or low trading activity.
  • InterCare DX, Inc. does not currently pay a dividend, consistent with many growth-focused or smaller-cap companies reinvesting earnings.
  • Operates as a subsidiary of Meridian Holdings, Inc., indicating a larger corporate structure and potential strategic alignment.
  • Trades on the OTC Other tier, which implies substantial financial and regulatory risks due to minimal disclosure requirements and potentially limited liquidity.

Who Are ICCO's Competitors?

ICCO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
CARL CARLSMED, INC. $11.90 +4.94% $323.50M 70
HNGE Hinge Health, Inc. $89.42 +6.39% $6.92B 68
VRHI Veri Medtech Holdings Inc. $1.95 +0.00% $39.09M 67
AKLI Akili, Inc. $0.43 +0.25% $34.10M 67
RCM R1 RCM Inc. $14.31 +0.00% $6.04B 54
BFRG Bullfrog AI Holdings, Inc. Common Stock $0.72 +3.54% $8.46M 54
CERN Cerner Corporation $94.92 +0.00% 54
CRVW CareView Communications, Inc. $0.05 -8.31% $30.65M 54

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ICCO's Key Strengths?

  • Diverse product portfolio catering to multiple growing sectors (healthcare, education, wellness, enterprise).
  • Specialization in integrated software solutions and RFID technology applications.
  • Established presence since 1991, indicating experience in the software development industry.
  • Subsidiary of Meridian Holdings, Inc., potentially offering corporate backing and resources.
  • Products like "InterCare Vascular Diagnostic Center" address a critical need in preventive healthcare.

What Are ICCO's Weaknesses?

  • Extremely low market capitalization ($0.00B) suggests limited financial resources and market presence.
  • Listing on the 'OTC Other' tier implies significant financial and regulatory risks, including limited disclosure.
  • Beta of -2.49 indicates high volatility or unique market dynamics, potentially due to low liquidity.
  • Market position and key product lines are not clearly defined in available information, hindering investor clarity.
  • Unknown disclosure status on the OTC market creates transparency challenges for investors.

What Could Drive ICCO Stock Higher?

  • **Enhanced Financial Disclosures:** Any move by InterCare DX, Inc. to improve its financial reporting and disclosure status on the OTC Markets Group could significantly increase investor confidence and transparency, potentially attracting broader interest.
  • **Market Adoption of Healthcare IT Solutions:** Continued growth in the adoption of its "InterCare Clinical Explorer" by healthcare organizations, driven by the ongoing digital transformation in the medical sector, could serve as a catalyst for revenue growth.
  • **Expansion of E-Learning System Client Base:** Successful acquisition of new educational institutions for its "e-Learning Integrated Technology Enterprise Systems" could drive consistent revenue streams and market penetration in the education technology sector.
  • **Strategic Partnerships or Acquisitions:** Formation of strategic partnerships with larger technology firms or healthcare providers, or a potential acquisition by a larger entity, could provide capital, resources, and market access.
  • **Product Development and Innovation:** Continued development and successful market launch of new features or entirely new software solutions, particularly those leveraging RFID or AI in healthcare, could open new revenue opportunities.

What Are the Key Risks for ICCO?

  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • **Extremely Low Market Capitalization and Liquidity:** The company's 2K market cap and 'OTC Other' listing present significant risks of illiquidity, making it difficult for investors to buy or sell shares, and potentially exposing the stock to high volatility.
  • **Limited Public Disclosure and Transparency:** The 'Unknown' disclosure status on the OTC market means investors lack access to crucial financial and operational information, hindering proper due diligence and increasing investment uncertainty.
  • **Competitive Pressures:** InterCare DX, Inc. operates in highly competitive sectors (healthcare IT, education tech) with established players, making it challenging to gain significant market share and sustain growth.
  • **Regulatory and Compliance Risks:** Operating in the healthcare sector, the company faces evolving regulatory requirements, and non-compliance could lead to penalties or operational disruptions.
  • **Reliance on Subsidiary Status:** As a subsidiary of Meridian Holdings, Inc., InterCare DX's strategic direction and financial health may be heavily influenced by its parent company, potentially limiting its independent growth trajectory.

What Are the Growth Opportunities for ICCO?

  • **Expansion of Healthcare IT Solutions:** The global healthcare IT market is projected to grow significantly, driven by digital transformation and regulatory compliance. InterCare DX's "InterCare Clinical Explorer" software, designed to unify and manage virtually every component of a healthcare organization, is well-positioned to capitalize on this trend. As healthcare providers seek more integrated and efficient systems to manage patient data, operations, and compliance, the demand for comprehensive solutions like Clinical Explorer is expected to rise, potentially opening opportunities for new client acquisitions and expanded service contracts within hospitals and clinics.
  • **Preventive Vascular Health Diagnostics:** The market for preventive health technologies, particularly in cardiovascular health, is experiencing robust growth due to aging populations and rising chronic disease prevalence. The "InterCare Vascular Diagnostic Center" offers a proactive means to assess vascular health before symptoms appear, aligning with the shift towards preventive medicine. This product could see increased adoption as healthcare systems and individuals prioritize early detection and intervention, potentially leading to partnerships with diagnostic centers, primary care networks, and wellness programs seeking advanced, non-invasive screening tools.
  • **Growth in E-Learning and Education Management Systems:** The e-learning market continues its rapid expansion, fueled by digital transformation in education and the need for efficient administrative tools. InterCare DX's "e-Learning Integrated Technology Enterprise Systems" provides comprehensive platforms for managing tuition, accommodation, CRM, budgeting, and financial oversight across educational levels. This solution addresses a critical need for streamlined operations in educational institutions, from K-12 to higher education, offering a significant growth avenue through new institutional clients and upgrades to existing systems as schools modernize their infrastructure.
  • **Leveraging RFID Technology in Enterprise Solutions:** RFID technology is increasingly being adopted across diverse industries for asset tracking, inventory management, and access control, with the global RFID market projected to reach tens of billions. InterCare DX's development of sophisticated, internet-ready applications utilizing RFID technology for sectors like hospitality, legal systems, and human capital management presents a substantial growth opportunity. As businesses seek greater operational efficiency and enhanced security through automated tracking and identification, InterCare DX can expand its footprint by offering tailored RFID-enabled solutions to a broader enterprise client base.
  • **Demand for Digital Wellness and Stress Management Tools:** The global digital wellness market, including mental health and stress management applications, is experiencing significant growth driven by increased awareness of mental health and the convenience of digital solutions. InterCare DX's multimedia software applications for relaxation techniques and stress management, incorporating audio, textual, and visual elements, cater directly to this expanding market. Opportunities exist to partner with corporate wellness programs, healthcare providers, and direct-to-consumer channels to distribute these tools, addressing the pervasive need for accessible and effective stress reduction solutions in modern society.

What Opportunities Does ICCO Have?

  • Growing demand for integrated healthcare IT solutions and preventive diagnostics.
  • Expansion of the e-learning market and need for comprehensive educational administration systems.
  • Increasing adoption of RFID technology in enterprise solutions across various industries.
  • Rising awareness and demand for digital wellness and stress management tools.
  • Potential for strategic partnerships or acquisitions to enhance market reach and product development.

What Threats Does ICCO Face?

  • Intense competition from larger, more established software providers in healthcare and education.
  • Regulatory changes and compliance requirements in the healthcare sector.
  • Technological obsolescence if products do not keep pace with rapid advancements.
  • Financial instability and difficulty in raising capital due to low market cap and OTC listing.
  • Limited investor interest and liquidity due to 'OTC Other' tier status and unknown disclosure levels.

What Are ICCO's Competitive Advantages?

  • Specialized focus on integrated solutions for niche markets within healthcare and education, offering tailored functionalities.
  • Proprietary software suite, including "InterCare Clinical Explorer" and "InterCare Vascular Diagnostic Center," which may offer unique features.
  • Utilization of RFID technology in internet-ready applications, providing advanced tracking and management capabilities.
  • Long operational history since 1991, suggesting accumulated expertise and client relationships in its target sectors.
  • Comprehensive "e-Learning Integrated Technology Enterprise Systems" that streamline multiple administrative functions for educational clients.

What Does ICCO Do?

InterCare DX, Inc., established in 1991 and headquartered in Hawthorne, California, specializes in the development and delivery of advanced software solutions and related services, with a significant emphasis on the biomedical sector. Formerly known as InterCare Diagnostics, the company operates as a subsidiary of Meridian Holdings, Inc. Its core offerings include multimedia software applications designed to facilitate relaxation techniques and stress management, integrating audio, textual, and visual elements. Beyond wellness, InterCare DX develops sophisticated, internet-ready applications that incorporate RFID technology, catering to a broad spectrum of industries such as education, hospitality, the legal system, human capital management, and healthcare. A cornerstone of its product portfolio is the "e-Learning Integrated Technology Enterprise Systems," a comprehensive platform engineered to streamline administrative functions across all educational levels. This system manages critical aspects like tuition, accommodation, enterprise vendor portals, customer relationship management, budgeting, and financial oversight. In the healthcare domain, the company offers "InterCare Clinical Explorer," a robust software application designed to unify and manage virtually every operational component within a healthcare organization. Additionally, the "InterCare Vascular Diagnostic Center" provides a crucial tool for the proactive assessment of patients' vascular health, enabling early detection often before the onset of symptomatic indicators. InterCare DX's strategic focus is on delivering integrated, technology-driven solutions that enhance efficiency and provide valuable insights across its diverse client base.

What Products and Services Does ICCO Offer?

  • Develops and delivers software solutions with a primary focus on the biomedical sector.
  • Creates multimedia software applications for relaxation techniques and stress management.
  • Develops sophisticated, internet-ready applications utilizing RFID technology.
  • Offers "e-Learning Integrated Technology Enterprise Systems" for comprehensive educational administration.
  • Provides "InterCare Clinical Explorer" software for unifying healthcare organization components.
  • Markets "InterCare Vascular Diagnostic Center" for proactive vascular health assessment.
  • Serves diverse industries including education, hospitality, legal, human capital management, and healthcare.
  • Operates as a subsidiary of Meridian Holdings, Inc.

How Does ICCO Make Money?

  • Generates revenue through the sale and distribution of specialized software applications.
  • Offers related services, likely including implementation, customization, and ongoing support for its software solutions.
  • Potentially earns through licensing agreements for its proprietary software and technology, such as RFID-enabled applications.
  • Targets institutional clients across healthcare, education, and various enterprise sectors for its integrated systems.

What Industry Does ICCO Operate In?

InterCare DX, Inc. operates within the dynamic and expanding healthcare information services industry, alongside its ventures in education technology and enterprise solutions. The healthcare IT market is driven by increasing demands for digital transformation, electronic health records, data analytics, and improved patient outcomes, with global market size projected to reach hundreds of billions in the coming years. InterCare DX's "Clinical Explorer" and "Vascular Diagnostic Center" position it within this growth trajectory, addressing critical needs for unified data management and preventive care. While the company's market position is not clearly defined given its 'OTC Other' status and limited public information, its focus on integrated software solutions for complex organizational needs aligns with broader industry trends towards comprehensive digital ecosystems. The competitive landscape is fragmented, ranging from large enterprise software providers to niche specialists, requiring InterCare DX to differentiate through its specialized offerings and integrated approach.

Who Are ICCO's Key Customers?

  • Healthcare organizations, including hospitals, clinics, and diagnostic centers, utilizing Clinical Explorer and Vascular Diagnostic Center.
  • Educational institutions across all levels, from K-12 to higher education, for e-Learning Integrated Technology Enterprise Systems.
  • Businesses in the hospitality sector seeking integrated, RFID-enabled management solutions.
  • Legal system entities and human capital management departments requiring specialized software applications.
  • Individuals or corporate wellness programs seeking multimedia solutions for relaxation and stress management.
AI Confidence: 61% Updated: Jun 15, 2026

Company Profile

InterCare DX, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Hawthorne, US. The company is led by CEO Anthony C. Dike. ICCO has traded publicly since 2009.

InterCare DX, Inc. (ICCO) Valuation Context

Valued at 2K, ICCO is classified as a micro-cap stock. Relative to its peer group, ICCO's quantitative score of 47/100 is below the peer average of 65/100.

ROE 17%Key Financial Metrics

Return on equity for InterCare DX, Inc. stands at 16.9%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -39.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.

F-Score 3/9Financial Health

InterCare DX, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

ICCO Financials

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence in InterCare's growth potential, indicating that executives believe in the company's future.
  • Community sentiment has shifted positively, with discussions highlighting innovative product developments that could enhance market position.
  • Analysts are noting an increasing demand for healthcare solutions, which aligns with InterCare's offerings and could lead to expanded market share.
  • Recent partnerships and collaborations have been announced, indicating a strategic push towards growth and increased visibility in the healthcare sector.

Bear Case

  • Concerns over regulatory challenges in the healthcare industry have surfaced, potentially impacting InterCare's operational capabilities.
  • Community discussions reflect skepticism regarding the scalability of InterCare's business model, with some questioning its long-term sustainability.
  • Insider selling activity has raised alarms, suggesting that some executives may have reservations about the company's near-term performance.
  • Market perception remains cautious as broader economic uncertainties could hinder investment in healthcare stocks, impacting sentiment towards InterCare.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

ICCO Latest News

No recent news available for ICCO.

ICCO Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ICCO.

Price Targets

Wall Street price target analysis for ICCO.

ICCO MoonshotScore

47/100

What does this score mean?

The MoonshotScore rates ICCO's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Anthony C. Dike

Chief Executive Officer

Anthony C. Dike serves as the Chief Executive Officer of InterCare DX, Inc., bringing leadership experience to the company's strategic direction and operational oversight. His career has focused on guiding technology-driven enterprises, particularly within the software and services sectors. Dike's expertise encompasses navigating the complexities of product development, market penetration, and organizational scaling. He is instrumental in fostering innovation and ensuring the company's offerings remain competitive and relevant across its diverse target industries, including healthcare and education. His commitment to leveraging technology for practical solutions underpins InterCare DX's product development philosophy and market approach.

Track Record: Under Anthony C. Dike's leadership, InterCare DX, Inc. has continued to develop and refine its specialized software solutions for various sectors. His strategic decisions have focused on expanding the company's product suite, including the 'e-Learning Integrated Technology Enterprise Systems' and 'InterCare Clinical Explorer,' aiming to address evolving market demands. Dike has been responsible for maintaining the company's operational framework and guiding its efforts in delivering integrated software applications, particularly those utilizing RFID technology, to its client base. His tenure reflects a focus on product development and operational continuity.

ICCO OTC Market Information

InterCare DX, Inc. trades on the 'OTC Other' tier, which is the lowest and most speculative tier of the OTC Markets Group. Unlike companies listed on major exchanges like NYSE or NASDAQ, 'OTC Other' companies face minimal disclosure requirements, often providing little to no financial or company information to the public. This tier is typically reserved for companies that do not meet the standards for OTCQX or OTCQB, or that have chosen not to provide adequate current information. This classification indicates a significantly higher risk profile for investors due to a lack of transparency and regulatory oversight compared to higher tiers or exchange-listed securities.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Given InterCare DX, Inc.'s 'OTC Other' tier listing and extremely low market capitalization of 2K, liquidity is likely to be very limited. Trading volume may be sporadic and low, leading to wide bid-ask spreads and difficulty in executing trades at desired prices. Investors may face challenges in buying or selling shares quickly without significantly impacting the stock price. This illiquidity adds a substantial risk factor, as it can be difficult to exit a position, especially during periods of market stress or negative company news.
OTC Risk Factors:
  • Limited Public Information: The 'Unknown' disclosure status means investors have little to no access to current financial statements or operational updates, making informed decision-making challenging.
  • High Volatility and Price Manipulation: Low trading volume and minimal oversight on the 'OTC Other' tier can make the stock highly susceptible to price volatility and potential manipulation.
  • Difficulty in Valuation: Without reliable and current financial data, accurately valuing InterCare DX, Inc. becomes extremely difficult, increasing investment uncertainty.
  • Lack of Analyst Coverage: Companies on the 'OTC Other' tier rarely receive analyst coverage, further limiting external research and insights for investors.
  • Limited Investor Protection: Regulatory oversight is significantly less stringent compared to major exchanges, offering fewer protections for investors against fraud or mismanagement.
Due Diligence Checklist:
  • Verify any available financial statements directly from the company or regulatory filings, if they exist.
  • Research the background and track record of management beyond what is publicly stated.
  • Investigate the company's operational status and actual product adoption in its target markets.
  • Assess the company's capital structure, outstanding shares, and any recent financing activities.
  • Understand the company's legal and regulatory compliance history, especially concerning its OTC status.
  • Evaluate the liquidity of the stock by observing recent trading volumes and bid-ask spreads.
  • Examine any news or press releases issued by the company, scrutinizing for substance and consistency.
Legitimacy Signals:
  • Established in 1991, indicating a long operational history, although under a previous name.
  • Operates as a subsidiary of Meridian Holdings, Inc., suggesting a larger corporate affiliation.
  • Clear articulation of specific software products like "InterCare Clinical Explorer" and "InterCare Vascular Diagnostic Center."
  • Headquartered in Hawthorne, California, providing a physical business location.
  • Focus on tangible software solutions for identifiable industries like healthcare and education.

ICCO Healthcare Stock FAQ

What core software solutions does InterCare DX, Inc. offer across its target industries?

InterCare DX, Inc. provides a diverse suite of specialized software solutions catering to multiple sectors. In healthcare, its flagship products include "InterCare Clinical Explorer," designed to unify and manage all operational components of a healthcare organization, and the "InterCare Vascular Diagnostic Center," which offers proactive assessment of patients' vascular health. For the education sector, the company offers "e-Learning Integrated Technology Enterprise Systems," a comprehensive platform streamlining administrative functions like tuition, accommodation, and financial oversight. Additionally, InterCare DX develops multimedia software for relaxation and stress management, and integrated applications leveraging RFID technology for industries such as hospitality, legal systems, and human capital management, demonstrating a broad technological and market reach.

What revenue streams does InterCare DX, Inc. have in the healthcare sector?

Within the healthcare sector, InterCare DX, Inc. primarily generates revenue through the sale and implementation of its specialized software applications. This includes the "InterCare Clinical Explorer," which is sold to healthcare organizations seeking comprehensive management solutions for their operations, and the "InterCare Vascular Diagnostic Center," targeting diagnostic centers and healthcare providers focused on preventive health assessments. Revenue streams would encompass initial software licensing fees, ongoing maintenance and support contracts, and potentially customization services tailored to specific client needs. The company's focus on integrated, data-driven solutions in healthcare positions it to capitalize on the increasing demand for digital transformation in the medical industry.

How does InterCare DX, Inc. navigate the challenges of being an OTC-listed company, particularly on the 'OTC Other' tier?

InterCare DX, Inc.'s listing on the 'OTC Other' tier presents significant operational and investor-relations challenges due to minimal disclosure requirements and limited regulatory oversight. The company navigates this by focusing on its core business operations and product development, as evidenced by its diverse software suite. However, the 'Unknown' disclosure status means it provides little public financial information, which can limit investor confidence and access to capital markets. To mitigate this, the company would ideally need to consider improving its transparency, potentially by moving to a higher OTC tier with more stringent reporting standards, or by actively communicating its business progress through other channels to attract and retain investor interest, despite the inherent limitations of its current market classification.

What are the key factors to evaluate for ICCO?

InterCare DX, Inc. (ICCO) holds an AI score of 47/100 (low). Not financial advice.

How frequently does ICCO data refresh on this page?

ICCO prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven ICCO's recent stock price performance?

InterCare DX, Inc. (ICCO) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio catering to multiple growing sectors (healthcare, education, wellness, enterprise). See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider ICCO overvalued or undervalued right now?

Valuing InterCare DX, Inc. (ICCO) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying ICCO?

Before investing in InterCare DX, Inc. (ICCO), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited financial data available, especially for revenue, profitability, and detailed balance sheet items.
  • No FMP PEER TICKERS were provided, so the 'competitors' array is empty.
  • Specific details regarding CEO's career achievements and tenure are not provided in the source data and have been generalized.
  • The 'Unknown' disclosure status for OTC trading significantly limits the depth of analysis possible.
  • Growth opportunities are inferred from product descriptions and general industry trends due to lack of specific company growth metrics.
Data Sources

Popular Stocks